Lex Diagnostics: Scott O'Brien
Feb 22, 2023
Scott O'Brien has been appointed to the board of UK molecular point-of-care diagnostics company Lex Diagnostics. Most recently, he led corporate and commercial strategies at Specific Diagnostics and at GenMark Diagnostics. He holds a bachelor's degree in microbiology from the University of Wisconsin-Madison.